ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,353 | -74.2% | 93,729 | 0.0% | 0.00% | – |
| Q2 2023 | $47,802 | -19.0% | 93,729 | 0.0% | 0.00% | – |
| Q1 2023 | $59,049 | -2.9% | 93,729 | 0.0% | 0.00% | – |
| Q4 2022 | $60,839 | -62.2% | 93,729 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $161,000 | +38.8% | 93,729 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $116,000 | -66.6% | 93,729 | +57.3% | 0.00% | -50.0% |
| Q2 2019 | $347,000 | +1.8% | 59,580 | -32.7% | 0.00% | 0.0% |
| Q1 2019 | $341,000 | +105.4% | 88,580 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $166,000 | -40.5% | 88,580 | +1.7% | 0.00% | -50.0% |
| Q3 2018 | $279,000 | +6.1% | 87,080 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $263,000 | +124.8% | 87,080 | +520.9% | 0.00% | +100.0% |
| Q4 2015 | $117,000 | – | 14,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |